We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBG icon
176
Corebridge Financial
CRBG
$15B
$1.49M 0.15%
42,087
+25,374
+152% +$789K
AEM icon
177
Agnico Eagle Mines
AEM
$90.5B
$1.49M 0.14%
12,492
-2,035
-14% -$236K
ALB icon
178
Albemarle
ALB
$15.5B
$1.47M 0.14%
+23,500
New +$1.39M
DOC icon
179
Healthpeak Properties
DOC
$14.8B
$1.47M 0.14%
+84,092
New +$1.49M
DAL icon
180
Delta Air Lines
DAL
$60.1B
$1.46M 0.14%
29,586
-38,708
-57% -$1.78M
NLY icon
181
Annaly Capital Management
NLY
$17.4B
$1.43M 0.14%
+76,180
New +$1.45M
SGRY icon
182
Surgery Partners
SGRY
$2.03B
$1.42M 0.14%
+63,939
New +$1.42M
SPLV icon
183
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$1.42M 0.14%
+19,439
New +$1.41M
FSLR icon
184
First Solar
FSLR
$26.9B
$1.41M 0.14%
+8,546
New +$1.26M
EQT icon
185
EQT Corp
EQT
$32.3B
$1.41M 0.14%
24,178
-25,662
-51% -$1.38M
BKNG icon
186
Booking.com
BKNG
$161B
$1.41M 0.14%
6,075
+1,900
+46% +$389K
LLY icon
187
Eli Lilly
LLY
$1.06T
$1.41M 0.14%
1,804
-702
-28% -$546K
MRVL icon
188
Marvell Technology
MRVL
$196B
$1.38M 0.13%
+17,838
New +$1.11M
FLGT icon
189
Fulgent Genetics
FLGT
$527M
$1.37M 0.13%
68,961
-14,850
-18% -$289K
AIV
190
Aimco
AIV
$383M
$1.35M 0.13%
156,460
-23,841
-13% -$193K
IBM icon
191
IBM
IBM
$224B
$1.35M 0.13%
4,581
+278
+6% +$71.6K
DT icon
192
Dynatrace
DT
$14.2B
$1.35M 0.13%
+24,412
New +$1.22M
WYNN icon
193
Wynn Resorts
WYNN
$10.6B
$1.35M 0.13%
14,370
-10,329
-42% -$876K
NXPI icon
194
NXP Semiconductors
NXPI
$60.4B
$1.33M 0.13%
6,086
+1,499
+33% +$293K
EXPE icon
195
Expedia Group
EXPE
$37.3B
$1.32M 0.13%
7,841
-1,951
-20% -$316K
EIDO icon
196
iShares MSCI Indonesia ETF
EIDO
$501M
$1.32M 0.13%
75,000
-27,000
-26% -$471K
SVT
197
DELISTED
Servotronics
SVT
$1.31M 0.13%
+27,877
New +$786K
JD icon
198
JD.com
JD
$44.5B
$1.31M 0.13%
+40,000
New +$1.36M
GH icon
199
Guardant Health
GH
$22.6B
$1.3M 0.13%
25,016
+7
+0% +$313
ALC icon
200
Alcon
ALC
$35B
$1.29M 0.13%
+14,589
New +$1.31M
6 7
8
9 10

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.